Gsk (GSK) Inventory (2009 - 2026)
Gsk (GSK) posted quarterly Inventory of $8.4 billion for Q2 2026, up 4.05% year-over-year from $8.1 billion in Q2 2025, and up 1.54% quarter-over-quarter from $8.3 billion in Q1 2026.
Gsk (GSK) Inventory (2009 - 2026) Analysis & Trends
Gsk's Inventory history runs 18 years deep, the most recent figure standing at $8.4 billion for Q2 2026.
- In Q2 2026, Inventory rose 4.05% year-over-year to $8.4 billion; the TTM figure through Jun 2026 stood at $8.4 billion (up 4.05% YoY), while the FY2025 annual figure was $7.8 billion, up 7.79% from the prior year.
- Inventory for Q2 2026 stood at $8.4 billion, up from $8.3 billion in the prior quarter.
- The five-year high for Inventory was $8.4 billion in Q2 2026, with the low at $1.3 billion in Q1 2022.
- The 5-year median for Inventory is $7.3 billion (2024), against an average of $6.9 billion.
- The sharpest annual moves came in 2022 and 2023: Inventory slumped 84.56% in 2022, then surged 391.97% in 2023.
- Gsk's Inventory stood at $6.0 billion in 2022, then increased by 13.05% to $6.8 billion in 2023, then gained by 6.63% to $7.3 billion in 2024, then increased by 8.3% to $7.9 billion in 2025, then grew by 6.96% to $8.4 billion in 2026.
- Business Quant data shows GSK's Inventory at $8.4 billion in Q2 2026, $8.3 billion in Q1 2026, and $7.9 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.85 Bn | 625.09 Bn | 17.26 Bn | 15.14 Bn |
| 2 | AbbVie | 464.52 Bn | 457.95 Bn | 12.70 Bn | 5.13 Bn |
| 3 | Merck | 371.03 Bn | 363.89 Bn | 12.21 Bn | 6.21 Bn |
| 4 | Novartis Ag | 298.88 Bn | 291.19 Bn | 11.24 Bn | 6.22 Bn |
| 5 | Astrazeneca | 255.79 Bn | 250.89 Bn | 12.86 Bn | 6.93 Bn |
| 6 | Amgen | 234.78 Bn | 220.79 Bn | 7.24 Bn | 6.22 Bn |
| 7 | Gilead Sciences | 179.58 Bn | 176.40 Bn | 6.22 Bn | 1.95 Bn |
| 8 | Pfizer | 159.12 Bn | 147.42 Bn | 10.94 Bn | 9.95 Bn |
| 9 | Gsk | 104.71 Bn | 100.55 Bn | 8.24 Bn | 8.43 Bn |
| 10 | Sanofi | 54.65 Bn | 47.27 Bn | 10.79 Bn | 12.93 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.43 Bn |
| Mar 31, 2026 | 8.30 Bn |
| Dec 31, 2025 | 7.88 Bn |
| Sep 30, 2025 | 8.26 Bn |
| Jun 30, 2025 | 8.10 Bn |
| Mar 31, 2025 | 7.56 Bn |
| Dec 31, 2024 | 7.28 Bn |
| Sep 30, 2024 | 7.69 Bn |
| Jun 30, 2024 | 7.40 Bn |
| Mar 31, 2024 | 7.23 Bn |
| Dec 31, 2023 | 6.82 Bn |
| Sep 30, 2023 | 6.94 Bn |
| Jun 30, 2023 | 6.90 Bn |
| Mar 31, 2023 | 6.51 Bn |
| Dec 31, 2022 | 6.04 Bn |
| Sep 30, 2022 | 5.49 Bn |
| Jun 30, 2022 | 5.87 Bn |
| Mar 31, 2022 | 1.32 Bn |
| Dec 31, 2021 | 7.80 Bn |
| Sep 30, 2021 | 8.61 Bn |